© 2004 by European Society of Cardiology
CASE REPORT
The head-up tilt test a cause of myocardial infarction
Cardiology Department, St George's Hospital Blackshaw Road, Tooting, London SW17 OQT, United Kingdom
Manuscript submitted 11 May 2004. Accepted after revision 2 August 2004.
*Corresponding author. 28 Bedford Road, Moor Park, Northwood, Middlesex HA6 2AZ, United Kingdom. Tel.: +44 1923 823599; fax: +44 1923 829229. E-mail address: mediderm{at}btinternet.com (S.I. Goolamali).
| Abstract |
|---|
|
|
|---|
INFARCTION: A 74-year-old man with no known ischaemic heart disease presented to the Cardiology Department with a history of multiple episodes of pre-syncope. During a head-up tilt test to investigate a neurocardiogenic cause, after glyceryl trinitrate provocation he became profoundly hypotensive and unwell. Subsequent ECGs and Troponin-T levels confirmed a Non ST-Elevation Myocardial Infarction. Angiography confirmed coronary artery disease. This case highlights a rare complication of tilt testing and emphasises that the test is not without risk.
Key Words: head-up tilt test, myocardial infarction
| Introduction |
|---|
|
|
|---|
Head-up tilt testing is generally considered a useful diagnostic aid in unexplained pre-syncopal and syncopal attacks.
Despite its good safety profile, complications have been reported in the literature including malignant ventricular arrhythmias [1,
2]
and coronary vasospasm [3]
although until now, these have only ever been recognized in association with isoprenaline provocation. We present a rare case of myocardial infarction induced by tilt testing potentiated with glyceryl trinitrate.
| Case report |
|---|
|
|
|---|
A 74-year-old male was referred to the cardiology clinic by his primary care physician for investigation of four episodes of pre-syncope over two years. These were not associated with chest pain, palpitations, collapse or neurological disturbance and all occurred whilst standing. He did have risk factors for cardiovascular disease specifically hypertension, hypercholesterolaemia and a history of heavy smoking. However, he was active and had never had symptoms clearly suggestive of myocardial ischaemia. His medication comprised 2.5 mg Bendrofluazide, 10 mg Simvastatin and 150 µg Thyroxine.
Cardiovascular examination and a resting ECG (Fig. 1) were normal. A subsequent 24 h Holter monitor was unremarkable except for occasional isolated ectopic beats. A head-up tilt test was arranged according to the protocol we use [4]
. This involves a supine stage of 10 min followed by a 60° head-up tilt with footboard support for a further 20 min. If negative, 400 µg glyceryl trinitrate (GTN) are then administered sublingually and monitoring is continued for a further 20 min. The heart rate and blood pressure are measured at 2 min intervals throughout the test and any symptoms noted.
|
He was hypertensive during the supine stage. On tilting, the sinus rate remained on average 85 beats/min but the systolic and diastolic blood pressures started to fall slowly with a trough blood pressure of 106/60 mmHg recorded at 16 min of tilt. The patient remained asymptomatic throughout. GTN was administered after 20 min which precipitated a rapid decrease in blood pressure to a trough blood pressure of 56/46 mmHg (VASIS Type 3) [5]
|
|
|
He has been on Aspirin, Ramipril and Simvastatin and has remained free of symptoms of ischaemia and pre-syncope for three months.
| Discussion |
|---|
|
|
|---|
The head-up tilt test is a common diagnostic procedure to help identify and classify vasovagal syncope. Pharmacological agents such as isoprenaline or glyceryl trinitrate can be used as a provocative stimulus. GTN provocation has demonstrated a high degree of specificity and sensitivity when identifying the vasovagal origin of unexplained syncope [6,
The procedure is non-invasive and generally very safe. However, ventricular fibrillation has been reported as a result of an isoprenaline provocation tilt test in a patient with known ischaemic heart disease [1]
. These authors subsequently recommended that patients with ischaemia should not undergo an isoprenaline challenge. Variant angina [10]
and inducible arrhythmias [11]
secondary to electrolyte disturbances have also been reported with isoprenaline. Wang et al. [2]
described a patient who developed severe coronary vasospasm during an isoprenaline tilt test.
To our knowledge myocardial infarction as a complication of tilt testing has not been reported previously nor have complications of GTN provocation. We consider that the hypotension induced by tilt testing compounded by GTN administration induced a myocardial infarction in the area supplied by our patient's diseased left circumflex coronary artery. The spontaneous pre-syncopes observed most likely reflected transient episodes of hypotension induced by myocardial ischaemia. Our case highlights the need for constant monitoring during and immediately after a tilt test. The careful selection of patients for such a test becomes important particularly if known risk factors for ischaemic heart disease are present.
| References |
|---|
|
|
|---|
[1] Leman RB, Clarke E, Gillette P. Significant complications can occur with ischaemic heart disease and tilt table testing. Pacing Clin Electrophysiol 1999; 22: 675677.[CrossRef][Medline]
[2] Wang C-H, Hung MJ, Kuo LT, Cherng WJ. Cardiopulmonary resuscitation during coronary vasospasm induced by tilt table testing. Pacing Clin Electrophysiol 2000; 23: 21382140.[CrossRef][Medline]
[3] Lip GY, Ray KK, Shiu MF. Coronary spasm in acute myocardial infarction. Heart 1998; 80: 197199.
[4] Del Rosso A, Bartoli P, Bartoletti A, et al. Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am Heart J 1998; 135: 564570.[CrossRef][Web of Science][Medline]
[5] Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P. Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1992; 2: 180183.
[6] Aerts A, Dendale P, Strobel G, Block P. Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope. Am Heart J 1997; 133: 504507.[CrossRef][Web of Science][Medline]
[7] Raviele A, Menozzi C, Brignole M, Gasparini G, Alboni P, Musso G, et al. Value of head-up tilt testing potentiated with sublingual nitroglycerine to assess the origin of unexplained syncope. Am J Cardiol 1995; 76: 267272.[CrossRef][Web of Science][Medline]
[8] Kapoor WN. Evaluation and outcome of patients with syncope. Medicine 1990; 69: 160175.[Medline]
[9] Kapoor WN. Evaluation and management of the patient with syncope. JAMA 1992; 268: 25532560.
[10] Jones S and Epstein A. Variant angina provoked by isoproterenol: an unusual cause of syncope. Am Heart J 1988; 116: 16281630.[CrossRef][Web of Science][Medline]
[11] Brembilla-Perrot B, Terrier de la Chaise A, le Van D, et al. Effect of isoproterenol on serum potassium and magnesium. Eur Heart J 1993; 14: 677681.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S W Parry, P Reeve, J Lawson, F E Shaw, J Davison, M Norton, R Frearson, S Kerr, and J L Newton The Newcastle protocols 2008: an update on head-up tilt table testing and the management of vasovagal syncope and related disorders Heart, March 1, 2009; 95(5): 416 - 420. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




